University Of Florence
Clinical trials sponsored by University Of Florence, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tests migraine drug as attack stopper Results expected Oct 2026 (estimated)
- Can talk therapy tame chronic migraine? small trial aims to find out Results expected Dec 2026 (estimated)
- Can talking and art ease fibromyalgia pain? Results expected Dec 2026 (estimated)
- New pill taken every other day could prevent migraines Results expected Jan 2027 (estimated)
- New study tests Nerve-Saving support for bladder cancer patients Results expected Sep 2027 (estimated)
-
New migraine drug shows promise in Real-World study
Disease control CompletedThis study looked at how well eptinezumab works and is tolerated for preventing migraines. It included 130 adults with episodic or chronic migraine. Researchers tracked changes in monthly migraine days over 3 to 12 months of treatment.
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Pill may replace shots for blood cancer patients, study finds
Disease control CompletedThis study tested whether an oral medication (CC-486) could help elderly patients with a serious blood disorder called myelodysplastic syndrome (MDS) maintain their improvement after initial injectable treatment. Eleven patients who had responded to injectable azacitidine switche…
Phase 2 • Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Stroke recovery at home: brain training may cut dementia risk
Disease control CompletedThis study tested whether a 40-hour, 8-week cognitive telerehabilitation program could reduce the risk of memory and thinking problems after a stroke. 86 adults who recently had a stroke were randomly assigned to either the home-based brain training or standard care. The program …
Sponsor: University of Florence • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New migraine pill lasmiditan shows promise in Real-World study
Symptom relief CompletedThis study looked at how well and how safely lasmiditan works for treating migraine attacks. One hundred adults with migraine took lasmiditan tablets (50, 100, or 200 mg) when they had an attack. Researchers measured how many people were pain-free after 2 hours and tracked any si…
Sponsor: University of Florence • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Blood and brain scans may predict stroke deterioration
Knowledge-focused CompletedThis completed study looked at 213 people with acute ischemic stroke to see if combining brain scans with blood tests could better predict complications like brain swelling or bleeding. Researchers also used a mouse model to study how brain cells change after stroke. The goal is …
Sponsor: University of Florence • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC